Shiff Susan Ph.D. reported TVRD

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001811463-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 9, 2026

Published

Jun 11, 2026

Ingested by INSIDER

Nov 5, 03:53 UTC

Last re-read

Nov 5, 03:53 UTC

Extracted facts

Filer

Shiff Susan Ph.D.

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Tvardi Therapeutics, Inc. — Stock Option (right to buy)

Ticker

TVRD

Shares

6,000

Price per share

$0

Execution date (reported)

Jun 9, 2026

Owned after transaction

6,000 shares

Days from execution to publication

2

What this establishes

Shiff Susan Ph.D. filed this Form 4 reporting a grant or award of TVRD on Jun 9, 2026. It became public on Jun 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Shiff Susan Ph.D.cik:0001811463

Issuer

Tvardi Therapeutics, Inc.cik:0001346830

Revision history · 0

No field has changed since this record was first ingested.